- Home
- RVNC vs KWR Comparison
RVNC vs KWR Comparison
Compare RVNC & KWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVNC
- KWR
- Stock Information
- Founded
- RVNC 1999
- KWR 1918
- Country
- RVNC United States
- KWR United States
- Employees
- RVNC N/A
- KWR N/A
- Industry
- RVNC Biotechnology: Pharmaceutical Preparations
- KWR Major Chemicals
- Sector
- RVNC Health Care
- KWR Industrials
- Exchange
- RVNC Nasdaq
- KWR Nasdaq
- Market Cap
- RVNC 546.4M
- KWR N/A
- IPO Year
- RVNC 2014
- KWR 1985
- Fundamental
- Price
- RVNC $5.20
- KWR $162.53
- Analyst Decision
- RVNC Buy
- KWR Strong Buy
- Analyst Count
- RVNC 10
- KWR 3
- Target Price
- RVNC $10.86
- KWR $201.67
- AVG Volume (30 Days)
- RVNC 2.3M
- KWR 115.8K
- Earning Date
- RVNC 11-06-2024
- KWR 10-31-2024
- Dividend Yield
- RVNC N/A
- KWR 1.19%
- EPS Growth
- RVNC N/A
- KWR 1334.24
- EPS
- RVNC N/A
- KWR 6.88
- Revenue
- RVNC $251,178,000.00
- KWR $1,891,047,000.00
- Revenue This Year
- RVNC $20.36
- KWR N/A
- Revenue Next Year
- RVNC $31.66
- KWR $3.95
- P/E Ratio
- RVNC N/A
- KWR $23.71
- Revenue Growth
- RVNC 40.23
- KWR N/A
- 52 Week Low
- RVNC $2.30
- KWR $138.67
- 52 Week High
- RVNC $9.90
- KWR $221.94
- Technical
- Relative Strength Index (RSI)
- RVNC 38.45
- KWR 47.42
- Support Level
- RVNC $5.08
- KWR $158.71
- Resistance Level
- RVNC $5.41
- KWR $162.29
- Average True Range (ATR)
- RVNC 0.19
- KWR 3.02
- MACD
- RVNC -0.01
- KWR -0.25
- Stochastic Oscillator
- RVNC 38.00
- KWR 26.81
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.